Axsome Therapeutics Inc.

NASDAQ: AXSM · Real-Time Price · USD
110.27
2.51 (2.33%)
At close: May 12, 2025, 3:41 PM

Axsome Therapeutics Revenue

Axsome Therapeutics reported an annual revenue of $385.69M, reflecting a 42.53% growth. For the quarter ending March 31, 2025, Axsome Therapeutics generated $121.46M in revenue.
Revenue (ttm)
$385.69M
Revenue Growth
42.53%
Price / Sales Ratio
10.51
Revenue / Employee
$541.7K
Employees
712
Market Cap
5.43B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.